Legend Star appeared to be the VC, which was created in 2008. The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
The top amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Legend Star works on 27 percentage points less the average amount of lead investments. The fund is constantly included in 7-12 investment rounds annually. When the investment is from Legend Star the average startup value is 50-100 millions dollars. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity.
Among the most popular portfolio startups of the fund, we may highlight Pony.ai, Burning Rock Biotech, Orvibo. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Mobile, Information Technology. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
We also calculated 3 valuable employees in our database.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Legend Star, startups are often financed by ZhenFund, Comet Labs, The Cross Country Group. The meaningful sponsors for the fund in investment in the same round are Legend Capital, Sequoia Capital China, LYFE Capital. In the next rounds fund is usually obtained by Sequoia Capital China, Legend Capital, Baidu Ventures.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CytoTronics | $13M | 05 Sep 2024 | Boston, Massachusetts, United States | ||
Healingovation | $9M | 14 May 2024 | Daxing, Beijing, China | ||
Arnatar Therapeutics | $50M | 08 Apr 2024 | San Diego, California, United States | ||
X Square | 01 Jan 2024 | - | |||
ENSEM Therapeutics | $10M | 23 Oct 2023 | Medford, Massachusetts, United States | ||
Carbon Energy Technology | $15M | 01 Sep 2023 | Beijing, Beijing, China | ||
CoJourney | $30M | 27 Jun 2023 | Hangzhou, Zhejiang, China | ||
China Reserve National Energy | $154M | 29 May 2023 | - | ||
Rgenta Therapeutics | $52M | 29 Nov 2022 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CytoTronics | $13M | 05 Sep 2024 | Boston, Massachusetts, United States | ||
Healingovation | $9M | 14 May 2024 | Daxing, Beijing, China | ||
Arnatar Therapeutics | $50M | 08 Apr 2024 | San Diego, California, United States | ||
X Square | 01 Jan 2024 | - | |||
ENSEM Therapeutics | $10M | 23 Oct 2023 | Medford, Massachusetts, United States | ||
Carbon Energy Technology | $15M | 01 Sep 2023 | Beijing, Beijing, China | ||
CoJourney | $30M | 27 Jun 2023 | Hangzhou, Zhejiang, China | ||
China Reserve National Energy | $154M | 29 May 2023 | - | ||
Rgenta Therapeutics | $52M | 29 Nov 2022 | Cambridge, Massachusetts, United States |